price
GN
NASDAQ · GNLX
Genelux Corporation
Healthcare · Biotechnology
$2.48
Down-$0.03 (-1.01%)
Updated Sep 11, 2026, 1:56 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 167.81M
- P/E ratio
- -5.24
- Dividend yield
- 0.00%
- 52-week range
- $2.29 – $3.25
- Volume
- 535.58K
- Avg. volume
- 233.63K
Price performance
GNLX price history
1M range · 20 trading sessions · Daily adjusted prices
GNLX closed at $2.48 after 20 trading sessions, down 5.70% for the selected period.
- Last close
- $2.48
- Period change
- -5.70%
- Period low
- $2.44
- Period high
- $2.88
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $2.55 | $2.73 | $2.41 | $2.48 | 535.58K |
| Sep 9, 2026 | $2.50 | $2.555 | $2.485 | $2.52 | 114.1K |
| Sep 8, 2026 | $2.50 | $2.54 | $2.39 | $2.54 | 408.29K |
| Sep 4, 2026 | $2.52 | $2.535 | $2.425 | $2.44 | 296.53K |
| Sep 3, 2026 | $2.55 | $2.58 | $2.46 | $2.52 | 510.44K |
| Sep 2, 2026 | $2.58 | $2.635 | $2.55 | $2.55 | 158.14K |
| Sep 1, 2026 | $2.63 | $2.66 | $2.5597 | $2.60 | 194.99K |
| Aug 31, 2026 | $2.67 | $2.77 | $2.56 | $2.615 | 328.49K |
| Aug 28, 2026 | $2.87 | $2.87 | $2.65 | $2.66 | 417.8K |
| Aug 27, 2026 | $2.72 | $2.95 | $2.72 | $2.88 | 594.43K |
| Aug 26, 2026 | $2.73 | $2.756 | $2.64 | $2.73 | 300.18K |
| Aug 25, 2026 | $2.73 | $2.82 | $2.67 | $2.72 | 352.91K |
| Aug 24, 2026 | $2.70 | $2.77 | $2.57 | $2.72 | 361.06K |
| Aug 21, 2026 | $2.78 | $2.81 | $2.684 | $2.72 | 223.75K |
| Aug 20, 2026 | $2.72 | $2.80 | $2.62 | $2.74 | 405.12K |
| Aug 19, 2026 | $2.64 | $2.79 | $2.63 | $2.68 | 317.44K |
| Aug 18, 2026 | $2.70 | $2.79 | $2.555 | $2.60 | 379.01K |
| Aug 17, 2026 | $2.76 | $2.76 | $2.63 | $2.70 | 265.15K |
| Aug 14, 2026 | $2.65 | $2.82 | $2.58 | $2.74 | 462.79K |
| Aug 13, 2026 | $2.70 | $2.76 | $2.61 | $2.63 | 315.71K |
Latest GNLX news
The latest Smart Investors Daily articles mentioning GNLX.
Stock researchCompany · Overview
Loading stock research…